We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Halfspace is a company that leverages advanced audience data management technology and analytics to offer comprehensive digital marketing and technology solutions to clients operating in the sports, entertainment, media, and gaming sectors. They are a data-driven marketing and technology group focused on serving the needs of the sports and entertainment industries.
days to go: Expired investment: £1,500,000
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go: Expired investment: £1,314,967
Adapttech aim to reduce the number of sessions needed to adjust a prosthetic to it’s owner, making prosthetics more comfortable at a much faster rate. Their technology uses a laser scanner combined wearale sensors to determine where the socket needs adjustments.
days to go: Expired investment: £1,225,000
Zentraxa is focused on precision bioengineering to produce peptides with predictable properties tailored towards purpose. The company points out that peptides are amino acids that are the building blocks of certain proteins needed by the skin, like collagen and elastin. It has come out with a synthetic biology platform, Zentide, that designs, produces and tests novel peptides. Zentraxa argues that Zentide can circumvent previously existing bio-design limits imposed by conventional peptide synthesis and produce tailor-made biomaterials for healthcare, personal care and industrial uses. Zentraxa is initially targeting healthcare with its first biomaterial, a debondable adhesive, for use in wound care. The company asserts that the material has other uses such as cosmetics and industrial applications due to its ability to bond strongly while still being easily and painlessly removable. Zentraxa will use the investment to create a portfolio of other biomaterials for licensing to global businesses in the health and industrial sectors via its Zentide platform. 
days to go: Expired investment: £1,040,000
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go: Stretch investment: £788,519
SkiBro is a leading business-to-customer (B2B) Software as a Service (SaaS) platform that aspires to become a contender in the €2 billion ski lessons market. The platform has onboarded 8,000 ski schools and 150,000 ski instructors to date. SkiBro's marketplace encompasses 350 resorts in 7 countries across Europe and North America, with over 6,000 ski instruction products. SkiBro intends to expand into ski hire. The platform has 350 independent ski instructors (250 last year) and 400+ ski schools, with notable ones including ESF La Plagne, ESF Courchevel, Evolution2 (France), Skischule Alberg (Austria), and Ski and Snowboard School Courmayeur (Italy). The company claims that despite COVID-19 hampering business in March 2020, the platform hosted 8.467 lesson bookings worth €1.35 million, recording a 500% YoY growth with an average booking value of €453. SkiBro is seeking £1.5 million of equity funding to accelerate company growth and deliver profitability in 2023-2024.
days to go: Expired investment: £749,825
Novus aspires to become the UK's first ethical digital bank. It argues that Generation Z and millennials want purpose-driven products and services that can also address environmental and social challenges of the times. The company asserts that its services align with the aforementioned objective. Novus allows its members to live a sustainable lifestyle by providing them access to sustainable brands through Novus' in-app marketplace and rewarding them via cashbacks. The company intends to undergo two more funding rounds – Series A and Series B – for scaling its UK operations and expanding in the US and other key EU markets within the next two years. It will IPO its business when it achieves profitability. The company also foresees a strategic exit to interested banking entities.
days to go: Expired investment: £732,000
Habitat Learn Group offers AI - powered speech-to-text solutions for students to over 300 Higher Education Institutions (HEIs) in North America and the UK, with advance semantics contextual linking tools enhancing its performance.
days to go: Expired investment: £730,000
SCRUBD specialise in grooming products specifically for men, leaving their skin feeling primed and looking great. SCRUBD use pioneering techniques and methods to create their 100% Natural products with no synthetic chemicals. Their skincare products are made in England and already have 72m Press Reach with more than 60+ pcs coverage.
days to go: Expired investment: £630,105
Koble claims that its data-driven Software as a Service (SaaS) tool helps accelerators and incubators streamline their selection process so they can focus on the most promising founders. The company's vision is to price early-stage startup risk and reward. It intends to move from a Software as a Service (SaaS) workflow tool to the startup-investor marketplace. Koble asserts that pre-seed and seed investors lack a quantitative approach in the early stage of recognising promising startups. Koble argues that its approach is different; it claims that its algorithms are built to mimic the decision processes (both analytical and intuitive) that humans go through when analysing a startup. The tool collects structured, well-tagged data that is not available in the public domain and power the first algorithms that can predict startup success. The company envisages three exit options, namely launching an IPO, avail buyout offers from big technology entities and avail buyout offers from financial buyers.
days to go: Expired investment: £525,500
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph